A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)
Titel:
A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)
Auteur:
Horinouchi, Hidehito Yamamoto, Noboru Nokihara, Hiroshi Horai, Takeshi Nishio, Makoto Ohyanagi, Fumiyoshi Horiike, Atsushi Nakagawa, Kazuhiko Terashima, Masaaki Okabe, Takafumi Kaneda, Hiroyasu McKee, Mark D. Carlson, Dawn M. Xiong, Hao Tamura, Tomohide